Seems like a good trade45-50 days of trade can give you 25-30%. dont invest too much in this period of crisis, just 40-50 shares, that is the minimum risk you should take,
tp 1350-1400, sl- 750-820
Long
NATCO Pharma Limited
No trades
No trades
Compare with NATCO Pharma Limited
63.35 INR
14.19 B INR
40.48 B INR
96.55 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
CEO
Rajeev Nannapaneni
Website
Headquarters
Hyderabad
Founded
1981
IPO date
Jan 23, 1995
ISIN
INE987B01026
FIGI
BBG000F4LSP2
Identifiers
ISIN INE987B01026
NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations segment operates in the divisions of oncology, pharma specialties and CnD. The International Formulations segment exports its FDF products from India to several international geographies either through its local partners or directly through its subsidiaries such as in Canada and Brazil. The Active Pharmaceutical Ingredients segment is strategically important as it develops APIs for the captive consumption of many of NATCO's critical FDF products in addition to supplying to direct customers. The company was founded by Venkaiah Chowdary Nannapaneni in 1981 and is headquartered in Hyderabad, India.
Long
Natco Pharma Remains Under Pressure Near Oversold ZoneHighlights
* Natco Pharma is trading around the ₹840–₹850 zone, with the stock remaining under considerable selling pressure. The broader chart structure is bearish, with the price below its important short- and long-term moving averages.
* Immediate support is visible around ₹835–₹840, follo
Natco Pharma - Keep On RadarCMP 857.60 on 28.08.26
Since Feb 2023, the rising trendline has been acting as an effective support level for the stock price. It is the 6th time, that the price is coming down to the support level.
If the trend continues, it may go into a bullish phase again. In that case, the indicative targets m
Long
NATCO Pharma: Wave C Bottom Could Set Up the Next Leg HigherNATCO Pharma appears to have completed the corrective A-B-C structure near 903 , with price now showing a strong recovery from the lower trendline. The immediate focus is on 938–940 , which is the key support zone for this setup. As long as price holds above this area, the recent rise can be treat
NatcopharmaCup and Hantle pattern in Natcopharma. After the handle breaks out its more 15 to 20 % up in the next few months
Long
NATCOPHARM-Multi month breakout.Multi Month Breakout, Price closes above Bollinger Band and expansion of Bollinger Bands started
Tgt-1 1,322
Long
Natco Pharma - Enough CorrectionCMP 875 on 22.05.25
The stock price dropped 50% between September 2024 and March 2025. In recent days, it has been consolidating near the 800 levels, which is acting as a support zone, as shown on the chart.
MACD shows a likely crossover, too.
If it gives an upside move, further targets may be 1080/
Long
Natco Pharma - Gap filling setup Natco Pharma - Gap filling setup
Technical Outlook
CMP : 1011
Chart Pattern
Stock had gapped down from 1189 to 1051 in Feb'25.
Since then, the stock seems to have settled down in a upward parallel channel as pointed out in the chart.
On weekly charts ,
EMA 9 is poised to crossover EMA 21, whi
Long
Natco Pharma monthly chart rsi signalJust observing the RSI indicator in the monthly charts. In its history whenever the monthly RSI does a bullish crossover the price goes on to make an eventual new high... so will history repeat itself this time around?
well one has to bit the bullet and stay invested to find out
Long
NATCO Pharma: Stage 2 Breakout Confirmed with Strong RSThe Core Thesis: Structural Shift to Leadership
NATCO Pharma has successfully completed a massive Stage 1 accumulation base (range between ₹795–₹1,030) and is now entering a high-probability Stage 2 advancing phase. This transition is backed by a significant "Change of Character" (CHoCH) and multi
Long
See all ideas
Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of NATCOPHARM is 784.80 INR — it has increased by 0.25% in the past 24 hours. Watch NATCO Pharma Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange NATCO Pharma Limited stocks are traded under the ticker NATCOPHARM.
NATCOPHARM stock has fallen by −3.34% compared to the previous week, the month change is a −3.04% fall, over the last year NATCO Pharma Limited has showed a −2.62% decrease.
We've gathered analysts' opinions on NATCO Pharma Limited future price: according to them, NATCOPHARM price has a max estimate of 1,180.00 INR and a min estimate of 706.25 INR. Watch NATCOPHARM chart and read a more detailed NATCO Pharma Limited stock forecast: see what analysts think of NATCO Pharma Limited and suggest that you do with its stocks.
NATCOPHARM reached its all-time high on Sep 12, 2024 with the price of 1,625.35 INR, and its all-time low was 7.55 INR and was reached on Oct 27, 2008. View more price dynamics on NATCOPHARM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NATCOPHARM stock is 0.99% volatile and has beta coefficient of 0.63. Track NATCO Pharma Limited stock price on the chart and check out the list of the most volatile stocks — is NATCO Pharma Limited there?
Today NATCO Pharma Limited has the market capitalization of 153.60 B, it has increased by 9.11% over the last week.
Yes, you can track NATCO Pharma Limited financials in yearly and quarterly reports right on TradingView.
NATCO Pharma Limited is going to release the next earnings report on Nov 17, 2026. Keep track of upcoming events with our Earnings Calendar.
NATCOPHARM earnings for the last quarter are 11.41 INR per share, whereas the estimation was 7.98 INR resulting in a 42.98% surprise. The estimated earnings for the next quarter are 9.07 INR per share. See more details about NATCO Pharma Limited earnings.
NATCO Pharma Limited revenue for the last quarter amounts to 7.35 B INR, despite the estimated figure of 7.58 B INR. In the next quarter, revenue is expected to reach 7.79 B INR.
NATCOPHARM net income for the last quarter is 2.06 B INR, while the quarter before that showed 2.68 B INR of net income which accounts for 0.00% change. Track more NATCO Pharma Limited financial stats to get the full picture.
NATCO Pharma Limited dividend yield was 0.51% in 2025, and payout ratio reached 6.31%. The year before the numbers were 0.75% and 5.70% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 16, 2026, the company has 5.06 K employees. See our rating of the largest employees — is NATCO Pharma Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NATCO Pharma Limited EBITDA is 10.52 B INR, and current EBITDA margin is 36.78%. See more stats in NATCO Pharma Limited financial statements.
Like other stocks, NATCOPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NATCO Pharma Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NATCO Pharma Limited technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NATCO Pharma Limited stock shows the sell signal. See more of NATCO Pharma Limited technicals for a more comprehensive analysis.